English (United States)

Prostate Cancer Registry

reduce font Size enlarge font Size print content

Prostate Cancer Registry - Population Key Facts

Analysis from Database 3 (January 2016) indicates that approximately two-thirds of patients were chemotherapy-naïve and almost half were receiving endocrine therapy at study entry.

A poster abstract was accepted for the ASCO meeting 2016 in Chicago reporting on how M-status at initial diagnosis may be indicator of future treatment and prognosis.

The poster presentation date is: Saturday 4th June, 1:00pm and 4:30pm. After this date, the poster will be available on the ASCO website: www.asco.org

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.